EP2330462B1 - Lithographic pellicle - Google Patents

Lithographic pellicle Download PDF

Info

Publication number
EP2330462B1
EP2330462B1 EP10014845.1A EP10014845A EP2330462B1 EP 2330462 B1 EP2330462 B1 EP 2330462B1 EP 10014845 A EP10014845 A EP 10014845A EP 2330462 B1 EP2330462 B1 EP 2330462B1
Authority
EP
European Patent Office
Prior art keywords
pellicle
frame
wall
excimer laser
arf excimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP10014845.1A
Other languages
German (de)
French (fr)
Other versions
EP2330462A1 (en
Inventor
Toru Shirasaki
Kenichi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Publication of EP2330462A1 publication Critical patent/EP2330462A1/en
Application granted granted Critical
Publication of EP2330462B1 publication Critical patent/EP2330462B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F1/00Originals for photomechanical production of textured or patterned surfaces, e.g., masks, photo-masks, reticles; Mask blanks or pellicles therefor; Containers specially adapted therefor; Preparation thereof
    • G03F1/62Pellicles, e.g. pellicle assemblies, e.g. having membrane on support frame; Preparation thereof
    • G03F1/64Pellicles, e.g. pellicle assemblies, e.g. having membrane on support frame; Preparation thereof characterised by the frames, e.g. structure or material, including bonding means therefor

Definitions

  • This invention relates to a lithographic pellicle for protecting a lithographic mask from dust or other debris during manufacture of semiconductor devices such as LSIs and VLSIs, and liquid crystal display panels.
  • the current LSI design rule reaches a finer size of the order of sub-quarter micron. Accordingly the light source for exposure becomes of a shorter wavelength. More particularly, the light source experiences a transition from g-line (436 nm) and i-line (365 nm) of a mercury lamp, which was the mainstream in the art, to KrF excimer laser (248 nm), ArF excimer laser (193 nm) or any shorter one.
  • patterns are formed by exposing semiconductor wafers or LC glass substrates to light.
  • the exposure step typically uses lithographic masks and reticles, which are collectively referred to as "exposure original plates", hereinafter. Problems arise if debris deposits on the exposure original plate. Since the debris absorbs or deflects light, the transferred pattern may be deformed or provided with rough edges, and the underlying layer may be contaminated black. These adversely impact the size, quality, and appearance of the pattern.
  • the pellicle is generally constructed of a pellicle frame and a transparent pellicle film.
  • the pellicle film is stretched across and mounted to the frame at its top end, and the frame at its bottom end is attached to an exposure original plate via a pressure-sensitive adhesive (PSA) layer.
  • PSA pressure-sensitive adhesive
  • the pellicle film is formed of nitrocellulose, cellulose acetate, fluoropolymers and similar materials which are fully transmissive to exposure light, for example, g-line (436 nm) and i-line (365 nm) of a mercury lamp, KrF excimer laser (248 nm), and ArF excimer laser (193 nm).
  • the pellicle film is mounted to the frame by applying a good solvent for the pellicle film to the top end of the pellicle frame, placing the pellicle film in contact with the top end, and air drying until a bond is formed, or by adhesively bonding the pellicle film to the top end of the frame using acrylic resin, epoxy resin or fluoro-resin base adhesives.
  • a PSA layer of polybutene resin, polyvinyl acetate resin, acrylic resin or silicone resin which is capable of attaching the frame to the exposure original plate. If necessary, a liner is attached to the PSA layer for the purpose of protecting the PSA layer.
  • the pellicle On use of the pellicle, it is attached to the exposure original plate by forcing them under pressure with the PSA layer sandwiched therebetween, so that the pellicle may enclose the pattern region on the surface of the exposure original plate.
  • the pellicle film, the pellicle frame and the exposure original plate define a closed pellicle space. Since the pellicle is provided for the purpose of preventing debris from depositing on the exposure original plate, the pattern region of the exposure original plate is isolated from the ambient atmosphere outside the pellicle so that dust in the ambient atmosphere may not deposit on the pattern surface.
  • the pellicle is provided for the purpose of preventing foreign particles from depositing on the pattern of the exposure original plate, the surfaces of the pellicle defining the closed pellicle space, that is, the lower surface of the pellicle film and the inner wall surface of the pellicle frame must be kept free of foreign particles.
  • foreign particles on the pellicle film can be detected having a size of down to about 0.3 ā‡ m.
  • the inner wall surface of the pellicle frame typically only foreign particles with a size of about 10 ā‡ m or larger can be detected. This means that even when a pellicle inspection detects no foreign particles on the frame inner wall, there can be present foreign particles with a size of less than 10 ā‡ m. Such foreign particles below the detectable level may fall on the exposure original plate during operation.
  • the inner wall of the pellicle frame is provided with an inner PSA layer as disclosed in JP-A S61-241756 . Even when foreign particles of undetectable size are present on the inner wall of the pellicle frame, the inner PSA layer on the inner wall of the pellicle frame holds the foreign particles adhered and prevents them from falling off the frame.
  • Second is ion residues on the exposure original plate.
  • Second is ionic and organic gases in the environment where the exposure original plate is used.
  • Third is ions and organic gases released from the pellicle. These ions and organic gases undergo photo-reaction upon receipt of ArF excimer laser radiation, forming solid precipitates on the pattern.
  • FIG. 3 schematically illustrates how ArF excimer laser radiation is scattered in a prior art lithographic pellicle.
  • the pellicle includes a pellicle film 1 and a pellicle frame 3.
  • the pellicle film 1 is stretched across pellicle frame 3 and bonded to the top end of pellicle frame 3 via an adhesive layer 2.
  • the pellicle is attached to an exposure original plate 5 via a PSA layer 4 so that the pellicle may enclose a mask pattern 9 formed on the surface of exposure original plate 5.
  • the inner wall of pellicle frame 3 is provided with an inner PSA layer 8.
  • an object of the present invention is to provide a pellicle which is minimized in decomposition gas generation and haze generation even when ArF excimer laser radiation impinges against the inner PSA layer during long-term service.
  • the inventors have found that when a curable composition comprising a perfluoro compound having a perfluoro structure backbone is used as the adhesive in the inner PSA layer on the inner wall of the pellicle frame, the pellicle is minimized in decomposition gas generation and haze generation.
  • the invention provides a lithographic pellicle comprising a pellicle frame having a top end, a bottom end, and an inner wall, a pellicle film stretched across and mounted to the pellicle frame at its top end, a pressure-sensitive adhesive layer disposed on the bottom end of the frame, capable of attaching the frame to a substrate, and an inner pressure-sensitive adhesive layer disposed on the inner wall of the frame and made of a curable composition as disclosed in claim 1
  • a curable composition comprising a perfluoro compound having a perfluoro structure backbone is used as the PSA in the inner PSA layer on the inner wall of the pellicle frame, the pellicle is minimized in decomposition gas generation and haze generation even when ArF excimer laser radiation impinges against inner PSA layer during long-term service.
  • the lithographic pellicle of the invention comprises a pellicle film, a pellicle frame, and a PSA layer.
  • the pellicle film is stretched across and mounted to the pellicle frame at its top end.
  • the PSA layer is disposed on the bottom end of the frame and is capable of attaching the frame to a substrate.
  • the components by which the pellicle is constructed are substantially the same as those of conventional pellicles, for example, pellicles for semiconductor lithography and pellicles for the manufacture of large-size LC display panels. They may be made of any well-known materials.
  • FIG. 1 a lithographic pellicle in one embodiment of the invention is illustrated as viewed from the bottom.
  • FIG. 2 is an elevational cross-sectional view taken along lines A-A in FIG. 1 when the pellicle is attached to an exposure original plate.
  • a pellicle 10 includes a pellicle frame 3 of generally quadrangular shape, typically rectangular or square shape, corresponding to an exposure original plate 5 to which the pellicle 10 is attached.
  • the pellicle frame 3 has a top end, a bottom end, an inner wall and an outer wall.
  • a pellicle film 1 is stretched across and mounted to pellicle frame 3 at its top end via an adhesive layer 2.
  • pellicle film 1 is made is not particularly limited, and any well-known materials may be used.
  • amorphous fluoropolymers as commonly used in the excimer laser application may be employed.
  • amorphous fluoropolymers include CytopĀ® from Asahi Glass Co., Ltd., and TeflonĀ® from DuPont. If necessary, upon formation of pellicle films, these polymers may be dissolved in solvents, typically fluorinated solvents and used in solution form.
  • the adhesive layer 2 is not necessarily essential for bonding of pellicle film 1. Where the adhesive layer 2 is provided, the adhesive of which layer 2 is made is not particularly limited. Any well-known adhesives may be used, including acrylic adhesives, silicone adhesives, and fluorochemical adhesives, for example.
  • the material of which pellicle frame 3 is made is not particularly limited, and any well-known materials may be used.
  • aluminum alloys commonly used in the art preferably aluminum alloys A7075, A6061, and A5052 according to the JIS nomination may be used. No particular limits are imposed on the aluminum alloy as long as it ensures a strength required for the pellicle frame.
  • the surface of pellicle frame 3 is preferably roughened by sand blasting, chemical polishing or the like, before the pellicle film and other components are mounted thereto. Any prior art well-known techniques may be employed for roughening the frame surface.
  • the aluminum alloy member may be surface roughened by blasting with stainless steel, silicon carbide, glass or other beads, and subsequent chemical polishing with NaOH or the like.
  • a PSA layer 4 Disposed at the bottom end of pellicle frame 3 is a PSA layer 4 capable of attaching pellicle frame 3 to an exposure original plate 5 which is typically a mask or reticle. If necessary, a release liner (not shown) for protecting the PSA layer is applied to the lower surface of PSA layer 4.
  • PSA layer 4 any suitable one may be chosen from a variety of PSAs including silicone, acrylic and polybutene base PSAs. Any well-known techniques may be used in applying the PSA in place.
  • the pellicle of the invention further includes an inner PSA layer 8 disposed on the inner wall of the pellicle frame and made of a curable composition comprising a perfluoro compound having a perfluoro structure as disclosed in claim 1.
  • an inner PSA layer 8 of tacky resin is disposed on the inner wall of pellicle frame 3.
  • the inner PSA layer 8 is made of any pressure-sensitive adhesives including fluorinated gel, rubber and resin compositions. Specifically, curable compositions comprising a perfluoro compound, typically a linear perfluoro compound, having a perfluoro structure backbone are used.
  • the perfluoro compound used herein is (A) a perfluoro compound having a perfluoroalkylene or perfluoropolyether structure in the backbone, having at least 2, more preferably 2 alkenyl groups in the molecule, and also a divalent linear perfluoroalkylene structure or divalent linear perfluoropolyether structure. Also useful is (B) a perfluoro compound having a perfluoroalkyl or perfluoropolyether structure in the backbone, preferably having one alkenyl group in the molecule, and also preferably a monovalent linear perfluoroalkyl structure or monovalent linear perfluoropolyether structure.
  • composition containing both perfluoro compounds (A) and (B).
  • the composition further comprises a component capable of reaction or crosslinking with the alkenyl-containing perfluoro compound, specifically an organosilicon compound having at least two hydrosilyl groups (SiH groups) in the molecule, and a catalyst for this reaction, specifically platinum group metal catalysts such as platinum and platinum compounds.
  • fluoroplastics are used in the pellicle film
  • fluoropolymers are generally resistant to light of short wavelength, experience less photo-degradation, and release least decomposed products.
  • the curable composition comprising a perfluoro compound having a perfluoro structure backbone is known from JP-A H11-116685 , for example, and commercially available under the trade name of SIFELĀ® 8000 series from Shin-Etsu Chemical Co., Ltd.
  • the pellicle of the invention is advantageous particularly when ArF excimer laser radiation is used as the exposure light.
  • any well-known methods may be employed in forming the PSA layer 8 on the pellicle frame inner wall.
  • a PSA liquid may be applied by brush or spray coating and cured by heating. If a PSA has too high a viscosity to coat, the PSA may be diluted with an organic solvent such as alcohol, water or the like to a lower viscosity sufficient to coat.
  • the inner PSA layer is preferably formed on the entire surface of the pellicle frame inner wall. The composition may be cured under any well-known conditions.
  • the pellicle of the invention is preferably provided with at least one vent hole 6 in the side wall of pellicle frame for providing fluid communication between the interior and exterior of pellicle frame 3 for pressure balancing.
  • a dust-proof filter 7 may be attached to the outer wall of the pellicle frame 3 so as to cover the hole 6 for the purpose of preventing entry of particles from without the pellicle.
  • the dust-proof filter may be any well-known one.
  • pellicle frame 3 is provided with only one vent hole 6 in FIGS. 1 and 2 , there may be provided two or more vent holes.
  • Example and Comparative Example are given below by way of illustration and not by way of limitation. Although a "maskā€ is referred to in Examples as a typical example of "exposure original plate,ā€ the same structure is equally applicable to "reticle.ā€
  • a pellicle frame of aluminum alloy (outer dimensions: 149 mm ā‡ 113 mm ā‡ 4.5 mm, wall thickness: 2 mm) was cleaned with deionized water.
  • the inner wall of the frame was coated with a 3% solution of a curable composition containing a linear perfluoro compound (trade name SIFEL 8070, Shin-Etsu Chemical Co., Ltd.) in a fluorochemical solvent (trade name NOVEC 7300, 3M-Sumitomo Co., Ltd.) by spray coating.
  • the coated frame was heated by electromagnetic induction heating for evaporating off the solvent and curing the coating.
  • the heating schedule included heating from room temperature to 150Ā°C over 1 minute and holding at 150Ā°C for 5 minutes. This resulted in an inner PSA layer of 20 ā‡ m thick.
  • the bottom end of the pellicle frame was coated with a silicone PSA (trade name X-40-3122, Shin-Etsu Chemical Co., Ltd.). Immediately thereafter, the frame was heated to 180Ā°C by electromagnetic induction heating for evaporating off the solvent, resulting in a bottom PSA layer of 0.3 mm thick.
  • the top end of the pellicle frame was coated with an adhesive CytopĀ® (trade name CTX-A, Asahi Glass Co., Ltd.), after which the frame was heated at 130Ā°C for curing the adhesive.
  • the pellicle frame at its top adhesive layer was brought in contact with a pellicle film of a fluoropolymer CytopĀ® (trade name CTX-S, Asahi Glass Co., Ltd.) stretched over an aluminum frame larger than the pellicle frame, after which a peripheral portion of the film outside the frame was removed, completing a pellicle.
  • a fluoropolymer CytopĀ® trade name CTX-S, Asahi Glass Co., Ltd.
  • the pellicle thus completed was attached to a mask having a pattern printed thereon.
  • ArF excimer laser radiation (193 nm) was irradiated to the mask at the surface (lower in FIG. 2 ) opposite to the surface (upper in FIG. 2 ) on which the pellicle was attached.
  • the ArF excimer laser had an oscillation frequency of 400 Hz and produced a radiation intensity of 0.05 mJ/cm 2 /pulse and a total irradiation energy dose of 15,000 J/cm 2 .
  • the area of irradiation was 10 ā‡ 10 mm.
  • the pellicle was removed from the mask.
  • the pattern surface of the mask exposed to ArF excimer laser radiation was observed under a scanning electron microscope (SEM), finding no growing foreign particles on the pattern surface.
  • a pellicle frame of aluminum alloy (outer dimensions: 149 mm ā‡ 113 mm ā‡ 4.5 mm, wall thickness: 2 mm) was cleaned with deionized water.
  • the inner wall of the frame was coated with a 3% solution of an acrylic PSA composition (trade name Corponeal 8694, Nippon Synthetic Chemical Industry Co., Ltd.) in toluene by spray coating. After spraying, the coated frame was heated by electromagnetic induction heating for evaporating off the solvent.
  • the heating schedule included heating from room temperature to 100Ā°C over 1 minute and holding at 100Ā°C for 5 minutes. This resulted in an inner acrylic PSA layer of 20 ā‡ m thick.
  • the bottom end of the pellicle frame was coated with a silicone PSA (trade name X-40-3122, Shin-Etsu Chemical Co., Ltd.). Immediately thereafter, the frame was heated to 180Ā°C by electromagnetic induction heating for evaporating off the solvent, resulting in a bottom PSA layer of 0.3 mm thick.
  • the top end of the pellicle frame was coated with an adhesive CytopĀ® (trade name CTX-A, Asahi Glass Co., Ltd.), after which the frame was heated at 130Ā°C for curing the adhesive.
  • the pellicle frame at its top adhesive layer was brought in contact with a pellicle film of a fluoropolymer CytopĀ® (trade name CTX-S, Asahi Glass Co., Ltd.) stretched over an aluminum frame larger than the pellicle frame, after which a peripheral portion of the film outside the frame was removed, completing a pellicle.
  • a fluoropolymer CytopĀ® trade name CTX-S, Asahi Glass Co., Ltd.
  • the pellicle thus completed was attached to a mask having a pattern printed thereon.
  • ArF excimer laser radiation (193 nm) was irradiated to the mask at the surface opposite to the surface on which the pellicle was attached.
  • the ArF excimer laser had an oscillation frequency of 400 Hz and produced a radiation intensity of 0.05 mJ/cm 2 /pulse and a total irradiation energy dose of 15,000 J/cm 2 .
  • the area of irradiation was 10 ā‡ 10 mm.
  • the pellicle was removed from the mask.
  • the pattern surface of the mask exposed to ArF excimer laser radiation was observed under SEM, finding growing foreign particles with an average particle size of 5 ā‡ m on the pattern surface.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Exposure And Positioning Against Photoresist Photosensitive Materials (AREA)
  • Preparing Plates And Mask In Photomechanical Process (AREA)

Description

    TECHNICAL FIELD
  • This invention relates to a lithographic pellicle for protecting a lithographic mask from dust or other debris during manufacture of semiconductor devices such as LSIs and VLSIs, and liquid crystal display panels.
  • BACKGROUND ART
  • The current LSI design rule reaches a finer size of the order of sub-quarter micron. Accordingly the light source for exposure becomes of a shorter wavelength. More particularly, the light source experiences a transition from g-line (436 nm) and i-line (365 nm) of a mercury lamp, which was the mainstream in the art, to KrF excimer laser (248 nm), ArF excimer laser (193 nm) or any shorter one.
  • In the manufacture of semiconductor devices (e.g., LSIs and VLSIs) and LC display panels, patterns are formed by exposing semiconductor wafers or LC glass substrates to light. The exposure step typically uses lithographic masks and reticles, which are collectively referred to as "exposure original plates", hereinafter. Problems arise if debris deposits on the exposure original plate. Since the debris absorbs or deflects light, the transferred pattern may be deformed or provided with rough edges, and the underlying layer may be contaminated black. These adversely impact the size, quality, and appearance of the pattern.
  • Although lithographic operations are typically performed in a clean room, it is still difficult to always maintain the exposure original plate clean. It is then a common practice to mount a pellicle on the surface of the exposure original plate for dust-proof protection before exposure is carried out. Then foreign particles do not deposit directly on the surface of the exposure original plate, but on the pellicle. The foreign particles on the pellicle do not contribute to the image transfer as long as the focus of lithographic projection is at the pattern on the exposure original plate.
  • The pellicle is generally constructed of a pellicle frame and a transparent pellicle film. The pellicle film is stretched across and mounted to the frame at its top end, and the frame at its bottom end is attached to an exposure original plate via a pressure-sensitive adhesive (PSA) layer. The pellicle film is formed of nitrocellulose, cellulose acetate, fluoropolymers and similar materials which are fully transmissive to exposure light, for example, g-line (436 nm) and i-line (365 nm) of a mercury lamp, KrF excimer laser (248 nm), and ArF excimer laser (193 nm). The pellicle film is mounted to the frame by applying a good solvent for the pellicle film to the top end of the pellicle frame, placing the pellicle film in contact with the top end, and air drying until a bond is formed, or by adhesively bonding the pellicle film to the top end of the frame using acrylic resin, epoxy resin or fluoro-resin base adhesives. Disposed on the bottom end of the pellicle frame is a PSA layer of polybutene resin, polyvinyl acetate resin, acrylic resin or silicone resin which is capable of attaching the frame to the exposure original plate. If necessary, a liner is attached to the PSA layer for the purpose of protecting the PSA layer.
  • On use of the pellicle, it is attached to the exposure original plate by forcing them under pressure with the PSA layer sandwiched therebetween, so that the pellicle may enclose the pattern region on the surface of the exposure original plate. The pellicle film, the pellicle frame and the exposure original plate define a closed pellicle space. Since the pellicle is provided for the purpose of preventing debris from depositing on the exposure original plate, the pattern region of the exposure original plate is isolated from the ambient atmosphere outside the pellicle so that dust in the ambient atmosphere may not deposit on the pattern surface. Since the pellicle is provided for the purpose of preventing foreign particles from depositing on the pattern of the exposure original plate, the surfaces of the pellicle defining the closed pellicle space, that is, the lower surface of the pellicle film and the inner wall surface of the pellicle frame must be kept free of foreign particles.
  • Typically foreign particles on the pellicle film can be detected having a size of down to about 0.3 Āµm. By contrast, on the inner wall surface of the pellicle frame, only foreign particles with a size of about 10 Āµm or larger can be detected. This means that even when a pellicle inspection detects no foreign particles on the frame inner wall, there can be present foreign particles with a size of less than 10 Āµm. Such foreign particles below the detectable level may fall on the exposure original plate during operation.
  • To avoid such spalling, the inner wall of the pellicle frame is provided with an inner PSA layer as disclosed in JP-A S61-241756 . Even when foreign particles of undetectable size are present on the inner wall of the pellicle frame, the inner PSA layer on the inner wall of the pellicle frame holds the foreign particles adhered and prevents them from falling off the frame.
  • Citation List
    • Patent Document 1: JP-A S61-241756
    • Patent Document 2: US 6040400 ( JP-A H11-116685 )
    DISCLOSURE OF INVENTION
  • Even so, particularly when the mask/pellicle for the ArF lithography is used over a long period, there may still arise a problem that solid foreign matter gradually precipitates on the pattern of the mask within the closed pellicle space to cause haze. Generally speaking, this problem is due to three causes. First is ion residues on the exposure original plate. Second is ionic and organic gases in the environment where the exposure original plate is used. Third is ions and organic gases released from the pellicle. These ions and organic gases undergo photo-reaction upon receipt of ArF excimer laser radiation, forming solid precipitates on the pattern.
  • Since the inner PSA layer on the pellicle frame inner wall is thin, only a minute amount of organic gases is released from the layer itself. Also, since the ArF excimer laser radiation is typically transmitted by the pattern region of the mask during use of the pellicle, no ArF excimer laser radiation impinges directly on the pellicle frame inner wall. However, it has recently been recognized that ArF excimer laser radiation is scattered at the edge of the pattern on the mask, and some scattering radiation impinges on the pellicle frame inner wall.
  • FIG. 3 schematically illustrates how ArF excimer laser radiation is scattered in a prior art lithographic pellicle. The pellicle includes a pellicle film 1 and a pellicle frame 3. The pellicle film 1 is stretched across pellicle frame 3 and bonded to the top end of pellicle frame 3 via an adhesive layer 2. The pellicle is attached to an exposure original plate 5 via a PSA layer 4 so that the pellicle may enclose a mask pattern 9 formed on the surface of exposure original plate 5. The inner wall of pellicle frame 3 is provided with an inner PSA layer 8. When ArF excimer laser radiation is incident on exposure original plate 5 as shown by the thick arrow, the majority of laser radiation is transmitted for transferring the pattern, for example, onto a semiconductor wafer (not shown). Part of laser radiation is scattered at the edge of mask pattern 9 on exposure original plate 5, with some scattering radiation moving toward pellicle frame 3. When scattering ArF excimer laser radiation impinges against inner PSA layer 8 on the inner wall of pellicle frame 3, the epoxy resin of which the inner PSA layer 8 is made (as disclosed in JP-A S61-241756 ), for example, is photo-decomposed to release gases. Such outgas undergoes photo-reaction by ArF excimer laser radiation within the pellicle closed space, causing solid precipitation or haze.
  • As ArF excimer laser radiation passes through the pellicle closed space, airborne oxygen within the pellicle closed space undergoes photo-reaction by ArF excimer laser radiation, producing ozone. Because of substantially no transfer of air into and out of the pellicle closed space, the ozone concentration increases within the pellicle closed space. As a result, the pellicle film, inner PSA layer and other components defining the pellicle closed space are exposed to ozone. Particularly when the inner PSA layer is made of a less weather resistant resin, for example, the resin is substantially degraded. Decomposition gas may be released when the resin is degraded, and the gas undergoes photo-reaction by ArF excimer laser radiation within the pellicle closed space, causing solid precipitation or haze.
  • Therefore, an object of the present invention is to provide a pellicle which is minimized in decomposition gas generation and haze generation even when ArF excimer laser radiation impinges against the inner PSA layer during long-term service.
  • The inventors have found that when a curable composition comprising a perfluoro compound having a perfluoro structure backbone is used as the adhesive in the inner PSA layer on the inner wall of the pellicle frame, the pellicle is minimized in decomposition gas generation and haze generation.
  • Accordingly, the invention provides a lithographic pellicle comprising a pellicle frame having a top end, a bottom end, and an inner wall, a pellicle film stretched across and mounted to the pellicle frame at its top end, a pressure-sensitive adhesive layer disposed on the bottom end of the frame, capable of attaching the frame to a substrate, and an inner pressure-sensitive adhesive layer disposed on the inner wall of the frame and made of a curable composition as disclosed in claim 1
  • ADVANTAGEOUS EFFECTS OF INVENTION
  • Since a curable composition comprising a perfluoro compound having a perfluoro structure backbone is used as the PSA in the inner PSA layer on the inner wall of the pellicle frame, the pellicle is minimized in decomposition gas generation and haze generation even when ArF excimer laser radiation impinges against inner PSA layer during long-term service.
  • BRIEF DESCRIPTION OF DRAWINGS
  • These and other features, aspects, and advantages of the present invention will become better understood when the following detailed description is read with reference to the accompanying drawings in which like characters represent like parts throughout the drawings.
    • FIG. 1 is a bottom view of a lithographic pellicle in one embodiment of the invention.
    • FIG. 2 is a cross-sectional view taken along lines A-A in FIG. 1, the pellicle being attached to an exposure original plate.
    • FIG. 3 schematically illustrates how ArF excimer laser radiation is scattered in a prior art lithographic pellicle.
    DESCRIPTION OF EMBODIMENTS
  • Unless defined otherwise, technical and scientific terms used herein have the same meaning as is commonly understood by one of skill in the art to which this invention belongs. The terms "a", "an" and "the" do not denote a limitation of quantity, but rather denote the presence of at least one of the referenced item. The terms "inner", "outer", "bottom", and/or "top", unless otherwise noted, are merely used for convenience of description, and are not limited to any one position or spatial orientation. The acronym "PSA" stands for pressure-sensitive adhesive.
  • The lithographic pellicle of the invention comprises a pellicle film, a pellicle frame, and a PSA layer. The pellicle film is stretched across and mounted to the pellicle frame at its top end. The PSA layer is disposed on the bottom end of the frame and is capable of attaching the frame to a substrate.
  • The components by which the pellicle is constructed are substantially the same as those of conventional pellicles, for example, pellicles for semiconductor lithography and pellicles for the manufacture of large-size LC display panels. They may be made of any well-known materials.
  • Referring to FIG. 1, a lithographic pellicle in one embodiment of the invention is illustrated as viewed from the bottom. FIG. 2 is an elevational cross-sectional view taken along lines A-A in FIG. 1 when the pellicle is attached to an exposure original plate. A pellicle 10 includes a pellicle frame 3 of generally quadrangular shape, typically rectangular or square shape, corresponding to an exposure original plate 5 to which the pellicle 10 is attached. The pellicle frame 3 has a top end, a bottom end, an inner wall and an outer wall. A pellicle film 1 is stretched across and mounted to pellicle frame 3 at its top end via an adhesive layer 2.
  • The material of which pellicle film 1 is made is not particularly limited, and any well-known materials may be used. For example, amorphous fluoropolymers as commonly used in the excimer laser application may be employed. Examples of amorphous fluoropolymers include CytopĀ® from Asahi Glass Co., Ltd., and TeflonĀ® from DuPont. If necessary, upon formation of pellicle films, these polymers may be dissolved in solvents, typically fluorinated solvents and used in solution form.
  • The adhesive layer 2 is not necessarily essential for bonding of pellicle film 1. Where the adhesive layer 2 is provided, the adhesive of which layer 2 is made is not particularly limited. Any well-known adhesives may be used, including acrylic adhesives, silicone adhesives, and fluorochemical adhesives, for example.
  • The material of which pellicle frame 3 is made is not particularly limited, and any well-known materials may be used. For example, aluminum alloys commonly used in the art, preferably aluminum alloys A7075, A6061, and A5052 according to the JIS nomination may be used. No particular limits are imposed on the aluminum alloy as long as it ensures a strength required for the pellicle frame.
  • The surface of pellicle frame 3 is preferably roughened by sand blasting, chemical polishing or the like, before the pellicle film and other components are mounted thereto. Any prior art well-known techniques may be employed for roughening the frame surface. When the pellicle frame is made of an aluminum alloy, for example, the aluminum alloy member may be surface roughened by blasting with stainless steel, silicon carbide, glass or other beads, and subsequent chemical polishing with NaOH or the like.
  • Disposed at the bottom end of pellicle frame 3 is a PSA layer 4 capable of attaching pellicle frame 3 to an exposure original plate 5 which is typically a mask or reticle. If necessary, a release liner (not shown) for protecting the PSA layer is applied to the lower surface of PSA layer 4.
  • For PSA layer 4, any suitable one may be chosen from a variety of PSAs including silicone, acrylic and polybutene base PSAs. Any well-known techniques may be used in applying the PSA in place.
  • The pellicle of the invention further includes an inner PSA layer 8 disposed on the inner wall of the pellicle frame and made of a curable composition comprising a perfluoro compound having a perfluoro structure as disclosed in claim 1. Specifically, as shown in FIGS. 1 and 2, an inner PSA layer 8 of tacky resin is disposed on the inner wall of pellicle frame 3.
  • The inner PSA layer 8 is made of any pressure-sensitive adhesives including fluorinated gel, rubber and resin compositions. Specifically, curable compositions comprising a perfluoro compound, typically a linear perfluoro compound, having a perfluoro structure backbone are used.
  • The perfluoro compound used herein is (A) a perfluoro compound having a perfluoroalkylene or perfluoropolyether structure in the backbone, having at least 2, more preferably 2 alkenyl groups in the molecule, and also a divalent linear perfluoroalkylene structure or divalent linear perfluoropolyether structure. Also useful is (B) a perfluoro compound having a perfluoroalkyl or perfluoropolyether structure in the backbone, preferably having one alkenyl group in the molecule, and also preferably a monovalent linear perfluoroalkyl structure or monovalent linear perfluoropolyether structure. Especially preferred is a curable composition containing both perfluoro compounds (A) and (B). The composition further comprises a component capable of reaction or crosslinking with the alkenyl-containing perfluoro compound, specifically an organosilicon compound having at least two hydrosilyl groups (SiH groups) in the molecule, and a catalyst for this reaction, specifically platinum group metal catalysts such as platinum and platinum compounds.
  • As understood from the fact that fluoroplastics are used in the pellicle film, fluoropolymers are generally resistant to light of short wavelength, experience less photo-degradation, and release least decomposed products. The curable composition comprising a perfluoro compound having a perfluoro structure backbone is known from JP-A H11-116685 , for example, and commercially available under the trade name of SIFELĀ® 8000 series from Shin-Etsu Chemical Co., Ltd.
  • Even in the case of fluoropolymers, it is difficult to control their decomposition completely. However, many decomposed products of fluoropolymers are less absorptive to light of short wavelength and undergo accordingly less reaction by ArF excimer laser radiation in the pellicle closed space, causing less haze. For this reason, the pellicle of the invention is advantageous particularly when ArF excimer laser radiation is used as the exposure light.
  • Any well-known methods may be employed in forming the PSA layer 8 on the pellicle frame inner wall. For example, a PSA liquid may be applied by brush or spray coating and cured by heating. If a PSA has too high a viscosity to coat, the PSA may be diluted with an organic solvent such as alcohol, water or the like to a lower viscosity sufficient to coat. The inner PSA layer is preferably formed on the entire surface of the pellicle frame inner wall. The composition may be cured under any well-known conditions.
  • The pellicle of the invention is preferably provided with at least one vent hole 6 in the side wall of pellicle frame for providing fluid communication between the interior and exterior of pellicle frame 3 for pressure balancing. A dust-proof filter 7 may be attached to the outer wall of the pellicle frame 3 so as to cover the hole 6 for the purpose of preventing entry of particles from without the pellicle. The dust-proof filter may be any well-known one. Although pellicle frame 3 is provided with only one vent hole 6 in FIGS. 1 and 2, there may be provided two or more vent holes.
  • EXAMPLE
  • Example and Comparative Example are given below by way of illustration and not by way of limitation. Although a "mask" is referred to in Examples as a typical example of "exposure original plate," the same structure is equally applicable to "reticle."
  • Example 1
  • A pellicle frame of aluminum alloy (outer dimensions: 149 mm Ɨ 113 mm Ɨ 4.5 mm, wall thickness: 2 mm) was cleaned with deionized water. The inner wall of the frame was coated with a 3% solution of a curable composition containing a linear perfluoro compound (trade name SIFEL 8070, Shin-Etsu Chemical Co., Ltd.) in a fluorochemical solvent (trade name NOVEC 7300, 3M-Sumitomo Co., Ltd.) by spray coating. After spraying, the coated frame was heated by electromagnetic induction heating for evaporating off the solvent and curing the coating. The heating schedule included heating from room temperature to 150Ā°C over 1 minute and holding at 150Ā°C for 5 minutes. This resulted in an inner PSA layer of 20 Āµm thick.
  • The bottom end of the pellicle frame was coated with a silicone PSA (trade name X-40-3122, Shin-Etsu Chemical Co., Ltd.). Immediately thereafter, the frame was heated to 180Ā°C by electromagnetic induction heating for evaporating off the solvent, resulting in a bottom PSA layer of 0.3 mm thick. The top end of the pellicle frame was coated with an adhesive CytopĀ® (trade name CTX-A, Asahi Glass Co., Ltd.), after which the frame was heated at 130Ā°C for curing the adhesive.
  • Thereafter, the pellicle frame at its top adhesive layer was brought in contact with a pellicle film of a fluoropolymer CytopĀ® (trade name CTX-S, Asahi Glass Co., Ltd.) stretched over an aluminum frame larger than the pellicle frame, after which a peripheral portion of the film outside the frame was removed, completing a pellicle.
  • The pellicle thus completed was attached to a mask having a pattern printed thereon. ArF excimer laser radiation (193 nm) was irradiated to the mask at the surface (lower in FIG. 2) opposite to the surface (upper in FIG. 2) on which the pellicle was attached. The ArF excimer laser had an oscillation frequency of 400 Hz and produced a radiation intensity of 0.05 mJ/cm2/pulse and a total irradiation energy dose of 15,000 J/cm2. The area of irradiation was 10Ɨ10 mm.
  • After irradiation, the pellicle was removed from the mask. The pattern surface of the mask exposed to ArF excimer laser radiation was observed under a scanning electron microscope (SEM), finding no growing foreign particles on the pattern surface.
  • Comparative Example 1
  • A pellicle frame of aluminum alloy (outer dimensions: 149 mm Ɨ 113 mm Ɨ 4.5 mm, wall thickness: 2 mm) was cleaned with deionized water. The inner wall of the frame was coated with a 3% solution of an acrylic PSA composition (trade name Corponeal 8694, Nippon Synthetic Chemical Industry Co., Ltd.) in toluene by spray coating. After spraying, the coated frame was heated by electromagnetic induction heating for evaporating off the solvent. The heating schedule included heating from room temperature to 100Ā°C over 1 minute and holding at 100Ā°C for 5 minutes. This resulted in an inner acrylic PSA layer of 20 Āµm thick.
  • The bottom end of the pellicle frame was coated with a silicone PSA (trade name X-40-3122, Shin-Etsu Chemical Co., Ltd.). Immediately thereafter, the frame was heated to 180Ā°C by electromagnetic induction heating for evaporating off the solvent, resulting in a bottom PSA layer of 0.3 mm thick. The top end of the pellicle frame was coated with an adhesive CytopĀ® (trade name CTX-A, Asahi Glass Co., Ltd.), after which the frame was heated at 130Ā°C for curing the adhesive.
  • Thereafter, the pellicle frame at its top adhesive layer was brought in contact with a pellicle film of a fluoropolymer CytopĀ® (trade name CTX-S, Asahi Glass Co., Ltd.) stretched over an aluminum frame larger than the pellicle frame, after which a peripheral portion of the film outside the frame was removed, completing a pellicle.
  • The pellicle thus completed was attached to a mask having a pattern printed thereon. ArF excimer laser radiation (193 nm) was irradiated to the mask at the surface opposite to the surface on which the pellicle was attached. The ArF excimer laser had an oscillation frequency of 400 Hz and produced a radiation intensity of 0.05 mJ/cm2/pulse and a total irradiation energy dose of 15,000 J/cm2. The area of irradiation was 10Ɨ10 mm.
  • After irradiation, the pellicle was removed from the mask. The pattern surface of the mask exposed to ArF excimer laser radiation was observed under SEM, finding growing foreign particles with an average particle size of 5 Āµm on the pattern surface.

Claims (5)

  1. A lithographic pellicle (10) comprising
    a pellicle frame (3) having a top end, a bottom end, and an inner wall,
    a pellicle film (1) stretched across and mounted to the pellicle frame (3) at its top end,
    a pressure-sensitive adhesive layer (4) disposed on the bottom end of the frame (3), capable of attaching the frame (3) to a substrate (5), and
    an inner pressure-sensitive adhesive layer (8) disposed on the inner wall of the frame (3) and made of a curable composition in the cured state, characterised in that,
    said curable composition comprises a perfluoro compound having a divalent perfluoroalkylene or perfluoropolyether structure in the backbone and has at least two alkenyl groups in the molecule, an organosilicon compound having at least two hydrosilyl groups in the molecule, and a platinum group metal catalyst.
  2. The pellicle of claim 1 wherein the divalent perfluoroalkylene or perfluoropolyether structure of the perfluoro compound is linear.
  3. The pellicle of claim 1 or 2 wherein the curable composition further comprises a perfluoro compound having a monovalent perfluoroalkyl or perfluoropolyether structure in the backbone and has one alkenyl group in the molecule.
  4. The pellicle of claim 3 wherein the monovalent perfluoroalkyl or perfluoropolyether structure of the perfluoro compound is linear.
  5. The pellicle of any one of claims 1 to 4 which is for ArF excimer laser radiation as the exposure light.
EP10014845.1A 2009-12-02 2010-11-22 Lithographic pellicle Active EP2330462B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009274283A JP5304622B2 (en) 2009-12-02 2009-12-02 Pellicle for lithography

Publications (2)

Publication Number Publication Date
EP2330462A1 EP2330462A1 (en) 2011-06-08
EP2330462B1 true EP2330462B1 (en) 2016-06-22

Family

ID=43652002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10014845.1A Active EP2330462B1 (en) 2009-12-02 2010-11-22 Lithographic pellicle

Country Status (7)

Country Link
US (1) US8394557B2 (en)
EP (1) EP2330462B1 (en)
JP (1) JP5304622B2 (en)
KR (1) KR101431304B1 (en)
CN (1) CN102096322B (en)
HK (1) HK1154084A1 (en)
TW (1) TWI488932B (en)

Families Citing this family (6)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
US9658525B2 (en) 2012-08-02 2017-05-23 Mitsui Chemicals Inc. Pellicle
JP5984187B2 (en) * 2013-04-22 2016-09-06 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle and photomask assembly
US9880462B2 (en) 2014-11-28 2018-01-30 Samsung Electronics Co., Ltd. Pellicle and exposure mask including the same
KR102251999B1 (en) * 2015-01-09 2021-05-17 ģ‚¼ģ„±ģ „ģžģ£¼ģ‹ķšŒģ‚¬ Pellicle and method of manufacturing the same
JP6395320B2 (en) * 2015-03-30 2018-09-26 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle
EP3079013B1 (en) * 2015-03-30 2018-01-24 Shin-Etsu Chemical Co., Ltd. Pellicle

Family Cites Families (13)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61241756A (en) 1985-04-19 1986-10-28 Hitachi Ltd Photomask
JPS6416685A (en) 1987-07-10 1989-01-20 Ricoh Kk Thermal transfer recording medium
JP2915744B2 (en) * 1993-04-13 1999-07-05 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle
JP3027073B2 (en) * 1993-07-28 2000-03-27 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle
JP3493090B2 (en) * 1995-12-15 2004-02-03 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle
TW337002B (en) 1996-11-19 1998-07-21 Mitsui Kagaku Kk Pellicle
JP3487744B2 (en) * 1997-10-09 2004-01-19 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Curable composition
JP4185233B2 (en) * 2000-03-10 2008-11-26 äæ”č¶ŠåŒ–å­¦å·„ę„­ę Ŗ式会ē¤¾ Pellicle for lithography
JP4195550B2 (en) * 2000-12-27 2008-12-10 äø‰äŗ•åŒ–å­¦ę Ŗ式会ē¤¾ Pellicle
US7094505B2 (en) * 2002-10-29 2006-08-22 Toppan Photomasks, Inc. Photomask assembly and method for protecting the same from contaminants generated during a lithography process
JP2006146085A (en) * 2004-11-24 2006-06-08 Shin Etsu Chem Co Ltd Large pellicle
JP2008065258A (en) * 2006-09-11 2008-03-21 Shin Etsu Chem Co Ltd Pellicle for lithography
JP2011113033A (en) * 2009-11-30 2011-06-09 Shin-Etsu Chemical Co Ltd Method and apparatus for producing pellicle film

Also Published As

Publication number Publication date
KR101431304B1 (en) 2014-08-20
EP2330462A1 (en) 2011-06-08
TW201134902A (en) 2011-10-16
JP2011118091A (en) 2011-06-16
CN102096322A (en) 2011-06-15
TWI488932B (en) 2015-06-21
JP5304622B2 (en) 2013-10-02
HK1154084A1 (en) 2012-04-13
US20110129766A1 (en) 2011-06-02
CN102096322B (en) 2014-03-12
US8394557B2 (en) 2013-03-12
KR20110063363A (en) 2011-06-10

Similar Documents

Publication Publication Date Title
EP2330462B1 (en) Lithographic pellicle
JP5189614B2 (en) Pellicle, method of attaching the pellicle, mask with pellicle and mask
TWI804221B (en) Protective film unit, photomask with attached pellicle unit, exposure method, semiconductor manufacturing method, and pellicle frame
US8192899B2 (en) Pellicle for photolithography
KR20130024878A (en) Photomask unit and method of manufacturing same
CN215449882U (en) Pellicle frame and pellicle, exposure original plate, exposure apparatus and exposure system, and manufacturing system
US8426084B2 (en) Pellicle for lithography
KR101524104B1 (en) Method for peeling pellicle and peeling device used for the method
CN215416267U (en) Pellicle frame and its assembly, exposure original plate, exposure system and manufacturing system
EP4163719A1 (en) Pellicle frame, pellicle, pellicle-equipped exposure original plate, exposure method, method for manufacturing semiconductor, and method for manufacturing liquid crystal display board
TWM634756U (en) Protective film frames, protective films, photomasks with protective films, exposure systems, manufacturing systems for semiconductor devices, and manufacturing systems for liquid crystal displays
JP2017187774A (en) Pellicle

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

17P Request for examination filed

Effective date: 20111206

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602010034128

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: G03F0001140000

Ipc: G03F0001640000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: G03F 1/64 20120101AFI20160204BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

INTG Intention to grant announced

Effective date: 20160216

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 808003

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010034128

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160922

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 808003

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160923

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161022

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161024

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010034128

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20170323

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20161122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161130

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161130

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161130

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161122

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20101122

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161122

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160622

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230929

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231010

Year of fee payment: 14

Ref country code: DE

Payment date: 20230929

Year of fee payment: 14